Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 8Breast Neoplasms 7Uterine Cervical Neoplasms 5Lung Neoplasms 5Hematopoietic and Lymphatic System Neoplasm 4Papillomavirus Infections 3Liver Neoplasms 2Hematologic Neoplasms 2Carcinoma, Intraductal, Noninfiltrating 2Carcinoma, Hepatocellular 2Pyloric Stenosis, Hypertrophic 1Prostatic Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Overweight 1Obesity 1Neoplasms 1Neoplasm Metastasis 1Multiple Myeloma 1Lymphoma 1Liver Diseases 1HER2+ Metastatic Breast Cancer (MBC) 1Fibrosis 1Diabetes Mellitus 1Colorectal Cancer Screening 1Colonic Neoplasms 1Cardiovascular Diseases 1Cancer Screening 1

Interventions

atezolizumab 2Control Groups 2Blood Specimen Collection 2Bevacizumab 2repotrectinib 1pembrolizumab 1durvalumab 1User-Centered Design 1Standard of Care 1Patient Navigation 1Neuropsychological Tests 1Neoadjuvant Therapy 1Liver Transplantation 1Injections 1Immunotherapy 1Electroporation 1Catheter Ablation 1Adjuvants, Pharmaceutic 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Liver Diseases × Patient Navigation × 1 year × Clear all
NCT02312817 2025-07-15

RCT of Screening Strategies Among Patients at High Risk for Developing HCC in a Safety-net Health System

University of Texas Southwestern Medical Center

Phase NA Completed
1,800 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡